level-one heading

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Burcin I.に依頼

United States

プロフィール概要

• Neuroscientist with over ten years of experience in studying neurodegenerative diseases • Science writer with a passion for promoting STEM education for children and making science and wellness accessible to everyone • Experienced manager with over five years of experience in leading, supervising and mentoring colleagues and students • Self-starter and independent researcher: initiated motor neuron disease research efforts in a pharmaceutical company, managed preclinical target development in a startup, and helped create a neurodegeneration challenge network in a foundation

専門分野

• ☆ Biology/Life Sciences
• ☆ Biostatistics
• ☆ Animal Genetics
• ☆ Molecular Biology
• ☆ Stem Cell Research
• ☆ Biomedical Engineering
• ☆ Neurology
• ☆ Neuropathology
• ☆ Technical & Scientific Writing

サービス

• Writing
• Consulting
• Data & AI
• Product Development

職務経験

Science Writer / Consultant

Chan Zuckerberg Initiative

9月 2017 - 現在

Senior Scientific Manager

Verge Genomics

2月 2016 - 7月 2017

Postdoctoral Scientist

Regeneron Pharmaceuticals

7月 2013 - 2月 2016

Graduate Research Scientist

Columbia University

8月 2007 - 6月 2013

学歴

PhD in Neurobiology

Columbia University

8月 2007 - 6月 2013

B.S. in Biomedical Computation

Stanford University

9月 2003 - 6月 2007

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, Siao CJ, Brydges S, LaRosa E, Bai Y, et al.(2016). C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice . Scientific reports.

(2015). The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis . Cell reports.

Re DB, Le Verche V, Yu C, Amoroso MW, Politi KA, Phani S, Ikiz B, Hoffmann L, Koolen M, Nagata T, et al.(2014). Necroptosis drives motor neuron death in models of both sporadic and familial ALS . Neuron.

(2009). Inflammation in ALS and SMA: sorting out the good from the evil . Neurobiology of disease.